Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BURNETT

Showing results (441-450 of 921) with videos related to

Pageof 93
Sort By:
Molecular Metabolism|March 9, 2017
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolismAnja Glöde, Jennifer Naumann, Thorsten Gnad, et al.
Protein Science : a Publication of the Protein Society|April 24, 2001
High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effectorM K Safo, C M Moure, J C Burnett, et al.
European Journal of Heart Failure|March 20, 2003
Leukemia inhibitory factor is augmented in the heart in experimental heart failureMichihisa Jougasaki, Hanna Leskinen, Amy M Larsen, et al.
The American Journal of Physiology|July 11, 1995
Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptideR R Brandt, D M Heublein, L L Aarhus, et al.
American Journal of Hypertension|June 11, 1992
Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dogD P Chan, E K Sandok, L L Aarhus, et al.
Journal of the American College of Cardiology|December 19, 1998
Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based studyA Luchner, J C Burnett, M Jougasaki, et al.
Journal of Cardiac Failure|August 6, 2013
Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarctionS Jeson Sangaralingham, John C Burnett, Paul M McKie, et al.
The Analyst|December 22, 2009
Improving limits of detection for B-type natriuretic peptide using PC-IDMS: an application of the ALiPHAT strategyChristopher M Shuford, Daniel L Comins, Jerry L Whitten, et al.
The American Journal of Physiology|January 11, 1988
Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhageB S Edwards, R S Zimmerman, T R Schwab, et al.
Expert Review of Molecular Diagnostics|January 24, 2014
Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discoveryErkan Kiris, Krishna P Kota, James C Burnett, et al.
Pageof 93

Showing results (441-450 of 921) with videos related to

Sort By:
Pageof 93
Molecular Metabolism|March 9, 2017
Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolismAnja Glöde, Jennifer Naumann, Thorsten Gnad, et al.
Protein Science : a Publication of the Protein Society|April 24, 2001
High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effectorM K Safo, C M Moure, J C Burnett, et al.
European Journal of Heart Failure|March 20, 2003
Leukemia inhibitory factor is augmented in the heart in experimental heart failureMichihisa Jougasaki, Hanna Leskinen, Amy M Larsen, et al.
The American Journal of Physiology|July 11, 1995
Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptideR R Brandt, D M Heublein, L L Aarhus, et al.
American Journal of Hypertension|June 11, 1992
Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dogD P Chan, E K Sandok, L L Aarhus, et al.
Journal of the American College of Cardiology|December 19, 1998
Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based studyA Luchner, J C Burnett, M Jougasaki, et al.
Journal of Cardiac Failure|August 6, 2013
Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarctionS Jeson Sangaralingham, John C Burnett, Paul M McKie, et al.
The Analyst|December 22, 2009
Improving limits of detection for B-type natriuretic peptide using PC-IDMS: an application of the ALiPHAT strategyChristopher M Shuford, Daniel L Comins, Jerry L Whitten, et al.
The American Journal of Physiology|January 11, 1988
Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhageB S Edwards, R S Zimmerman, T R Schwab, et al.
Expert Review of Molecular Diagnostics|January 24, 2014
Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discoveryErkan Kiris, Krishna P Kota, James C Burnett, et al.
Pageof 93